DAIC

APRIL 30, 2024

Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure , a leading cause of hospitalization and death. hospitals from emergency rooms.

Heart Failure 105

Heart Failure Hospital Research COVID-19 105

European Journal of Cardiovascular Nursing

JANUARY 21, 2025

Abstract Aims The COVID-19 pandemic disrupted healthcare systems and possibly impacted the management of heart failure (HF). A total of 85 564 completed admissions were identified, of which 45 080 were hospitalized in the pre-COVID-19 period and 40 484 were hospitalized in the COVID-19 impacted period.

COVID-19 40

COVID-19 Heart Failure Hospital Outcomes 40

SoftCath

MAY 22, 2021

The existence of the Covid-19 pandemic has shaken the lives of people around the world and is continuing to do so. Primarily, physicians were suspecting Covid-19 to be a respiratory disorder. Now let us move forward and study some other crucial impacts of Covid-19 on cardiology departments.

COVID-19 52

COVID-19 Blood Clot Technology Cardiovascular Disease 52

Dr. Anish Koka

FEBRUARY 6, 2023

I’m a cardiologist, and the first disconnect that became glaringly obvious very quickly was the impact COVID was having on the heart. As I walked through COVID rooms in the Spring of 2020 trying to hold my breath, I waited for a COVID cardiac tsunami. There never was a cardiac tsunami from COVID.

COVID-19 52

COVID-19 Chest Pain Academic Hospital 52

European Journal of Heart Failure

OCTOBER 9, 2023

Impact of COVID-19 in patients with HF and mildly reduced and preserved ejection fraction. COVID-19, coronvirus disease-2019; HF, heart failure. Aim COVID-19 may affect clinical risk in patients with heart failure. COVID-19 cases and deaths did not differ by randomized assignment.

Preserved Ejection Fraction 40

Preserved Ejection Fraction COVID-19 Heart Failure Hospital 40

Frontiers in Cardiovascular Medicine

MARCH 14, 2024

Extracorporeal membrane oxygenation (ECMO) and extracorporeal life support (ECLS) devices are well-established adjunctive treatment measures for patients with heart failure. However, the role of ECMO as a bridge to definitive therapy in a setting of acute heart failure is less established.

Bicuspid/Mitral 69

Bicuspid/Mitral Heart Failure COVID-19 Inpatient 69

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Ischemic heart disease (IHD) is one of the world's foremost killers, accounting for 16% of all deaths worldwide. IHD is the main cause of heart failure (HF), as it leads to pathological changes in the heart, improper pumping function and eventual death.

Heart Failure 59

Heart Failure Academic COVID-19 Innovation 59

DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. All secondary endpoints related specifically to heart failure outcomes were significantly reduced among patients who received empagliflozin.

Heart Attack 98

Heart Attack Heart attacks Heart Failure Outpatient 98

Journal of the American Heart Association

MARCH 21, 2025

We evaluated the association between social vulnerability and a composite of myocardial infarction, stroke, heart failure, venous thromboembolism, cardiogenic shock, cardiac arrest, and death, following discharge, using Cox regression models.

COVID-19 40

COVID-19 Medicare Cardiogenic Shock Hospital 40

DAIC

APRIL 9, 2024

Decline in exercise ability is a hallmark of progression to overt heart failure. These results also speak to the importance of continuing to focus on earlier recognition of heart failure risk in patients with diabetes and on initiating treatment before the condition has progressed to overt heart failure.”

Heart Failure 52

Heart Failure Diabetes Cardiomyopathy Exercise 52

Circulation: Cardiovascular Quality & Outcomes

NOVEMBER 1, 2023

Enhancing access to care using telehealth is a priority for improving outcomes among older adults with heart failure, increasing quality of care, and decreasing costs.

Heart Failure 40

Heart Failure COVID-19 Circulation Outcomes 40

Open Heart

DECEMBER 7, 2023

Background/objectives Heart failure (HF) is a growing clinical and economic burden for patients and health systems. The COVID-19 pandemic has led to avoidance and delay in care, resulting in increased morbidity and mortality among many patients with HF.

Heart Failure 40

Heart Failure COVID-19 Nursing Hospital 40

Open Heart

NOVEMBER 4, 2022

Introduction The diagnostic and therapeutic arsenal for heart failure with preserved ejection (HFpEF) has expanded. Methods A single-centre retrospective analysis of 202 HFpEF outpatients was performed over 12 months before the COVID-19 pandemic.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure COVID-19 Outpatient 52

DAIC

APRIL 6, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,

Heart Attack 81

Heart Attack Heart attacks Heart Failure Outcomes 81

European Journal of Heart Failure

OCTOBER 31, 2023

This 2023 Cochrane review of 60 randomized trials in 8728 heart failure patients, confirms the benefits of participation in exercise-based cardiac rehabilitation (ExCR), including reduced risk of hospitalization and a clinically meaningful improvement in health-related quality of life.

Cardiac Rehabilitation 40

Cardiac Rehabilitation Heart Failure Exercise Quality of Life 40

American College of Cardiology

AUGUST 30, 2024

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19-related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC.

COVID-19 40

COVID-19 Obesity Heart Failure Outcomes 40

Open Heart

FEBRUARY 17, 2024

Objective To evaluate stress, depression and quality of life among community-dwelling patients with heart failure (HF) and evaluate their effect on perceived medication adherence in a socioeconomically challenged setting.

Heart Failure 40

Heart Failure Quality of Life ACE Inhibitor COVID-19 40

European Journal of Heart Failure

MARCH 4, 2024

Patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) have a high risk of developing LRTI. No effect of empagliflozin was observed on COVID-19 incidence. Empagliflozin reduced the risk of lower respiratory tract infections. CI, confidence interval; HR, hazard ratio.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure COVID-19 Kidney Disease 40

European Journal of Heart Failure

DECEMBER 13, 2023

For the global rank score all participants were ranked across three hierarchical groups: Tier 1 = time to death or urgent heart transplantation or implantation of a ventricular assist device; Tier 2 = time to non-fatal HF requiring i.v. Due to the COVID-19 pandemic, the planned number of patients could not be recruited.

Heart Failure 40

Heart Failure COVID-19 Hospital Heart Transplant 40

Dr. Smith's ECG Blog

NOVEMBER 12, 2020

This is a 30-something healthy patient presented with COVID pneumonia who presented to the ED. An elevated troponin in a COVID patient confers about 4x the risk of mortality than a normal one. Beware elevated troponins in COVID patients. He was moderately hypoxic. There is minimal, probably normal STE in V2-V6. 3–8 Shi et al.

Cardiac Arrest 52

Cardiac Arrest COVID-19 Myocardial Infarction Cardiogenic Shock 52

Heart BMJ

MARCH 12, 2024

The primary outcome was a composite of all-cause mortality, new myocardial infarction or hospitalisation for heart failure at 12 months. Results The trial was discontinued early by the funder due to slow recruitment during the COVID-19 pandemic. hours (IQR: 0.9–2.0)) hours (IQR: 22.9–72.6)). –72.6)).

COVID-19 52

COVID-19 Myocardial Infarction Heart Failure Outcomes 52

Dr. Anish Koka

FEBRUARY 13, 2023

Arthur Reingold, an epidemiology professor at UC-Berkeley, notes that UC also requires immunizations for measles and chickenpox, and people still are dying from COVID at rates that exceed those for influenza. 1, there were more than 400 COVID deaths a day across the U.S. As of Feb. Almost a million followers now.

COVID-19 52

COVID-19 Public Health Pediatrics Chest Pain 52

Heart 2023 Conference

APRIL 20, 2022

(Heart) Meanwhile, cardioobstetrics training is critically inadequate in the United States (Journal of the American Heart Association) The Women's Health Initiative found that postmenopausal women with a history of infertility were more likely to develop incident heart failure with intact ejection fraction.

Pulmonary 52

Pulmonary Hypertension AFIB COVID-19 52

ADN Center of Excellence

SEPTEMBER 28, 2023

The Role of Cardiologists Cardiologists are at the forefront of the battle against heart diseases. Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects.

COVID-19 52

COVID-19 Heart Disease Education Interventional Cardiology 52

Dr. Malcolm Kendrick

OCTOBER 25, 2022

Hybrid Conference’ : ‘The RNA vaccines against COVID-19 mark the beginning of a technological revolution that will transform the way we treat disease and restore health. Maybe I should just attend this meeting ‘ The New Frontier of RNA Nanotherapeutic. Monday, October 24, 2022 8:30 a.m. – 5 p.m.

COVID-19 52

COVID-19 Blog Heart Attack Heart attacks 52

DAIC

AUGUST 29, 2024

She adds there are further potential advantages: “A remote robotic echo system may help protect more health professionals from the risk of exposure during pandemics like the COVID-19 as the cardiologist may not need to be in close contact with the patient if only echocardiogram consultation is required.”

Echocardiogram 52

Echocardiogram Bicuspid/Mitral Aortic valve COVID-19 52

Cardiology Update

DECEMBER 3, 2023

Chadi Alraies discusses highlights from the American Heart Association (AHA) Scientific Sessions 2023, which were held in Philadelphia, Pennsylvania (PA), on November 11-13, 2023. There were many important developments in presented in key clinical trial presentations and publications stemming from the AHA Scientific Sessions 2023.

Research 98

Research Cardio Oncology COVID-19 Heart Failure 98

Vector Remote

APRIL 14, 2023

Between the COVID-19 pandemic and increasing amount of chronic diseases found in patients, the need for virtual healthcare has taken flight at an accelerated pace. This has made access to high-quality remote healthcare services critical for both clinics and their patients.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

Cardiomatics

OCTOBER 10, 2022

The situation became particularly bad when the COVID-19 pandemic began. The scale of the problem is also shown by the average ambulance response time for category 2 calls (suspected heart attacks and strokes), which has risen to 59 minutes , whereas the target is 18 minutes. What are the reasons for this?

Heart attacks 52

Heart attacks Heart Attack Cardiovascular Disease COVID-19 52

Open Heart

FEBRUARY 4, 2025

Background Studies have shown an increased risk of cardiac disease following COVID-19, but how it compares to pneumonia of other etiologies is unclear. Aims To determine the incidence and HRs of cardiac disease in patients hospitalised with COVID-19 compared with other viral or bacterial pneumonias.

COVID-19 52

COVID-19 Myocardial Infarction Atrial Fibrillation Heart Failure 52

European Journal of Heart Failure

OCTOBER 30, 2023

Among 777 participants who received a COVID-19 mRNA-1273 booster vaccination, 40 (5.1%; 95% confidence interval [CI] 3.7–7.0%) Abstract Aims To explore the incidence and potential mechanisms of oligosymptomatic myocardial injury following COVID-19 mRNA booster vaccination. Females ( n  = 20, 3.7% [95% CI 2.3–5.7%])

COVID-19 40

COVID-19 Hospital Research Article 40

International Journal of Cardiovascular Sciences

OCTOBER 21, 2024

Award Winners: Arquivos Brasileiros de Cardiologia Best Original Article – Determining Percentiles of Atherosclerotic Cardiovascular Risk According to Sex and Age in a Healthy Brazilian Population Authors: Fernando Yue Cesena, Nea Miwa Kashiwagi, Carlos Andre Minanni, Raul D.

Article 52

Article Preserved Ejection Fraction COVID-19 Heart Failure 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Physiologically Speaking

APRIL 24, 2024

7 8 Sleep may have also played an underemphasized role in the COVID-19 pandemic. In a cohort of >3,000 people from the National Health and Nutrition Examination Survey (NHANES), sleeping <6 hours each night predicted a higher prevalence of stroke, heart attack, and chronic heart failure.

Blood Pressure 52

Blood Pressure Blood Clot COVID-19 Cardiovascular Disease 52

Dr. Smith's ECG Blog

DECEMBER 5, 2023

References Law YM, Lal AK, Chen S, Čiháková D, Cooper LT Jr, Deshpande S, Godown J, Grosse-Wortmann L, Robinson JD, Towbin JA; American Heart Association Pediatric Heart Failure and Transplantation Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young and Stroke Council.

Pediatrics 121

Pediatrics Pericarditis COVID-19 Congenital Heart Disease 121

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

Age, male sex, chronic kidney disease, arrhythmias, decompensated heart failure, requirement of inotropic/vasopressor, and invasive mechanical ventilation were related to higher mortality risk in patients with myocardial injury.ConclusionPatients with COVID-19 and myocardial injury exhibit a broad spectrum of cardiac abnormalities.

COVID-19 40

COVID-19 Hospital Kidney Disease Heart Failure 40